Entera Bio Ltd. (ENTX)
NASDAQ: ENTX · Real-Time Price · USD
1.630
0.00 (0.00%)
Jan 15, 2026, 10:35 AM EST - Market open
Entera Bio Market Cap
Entera Bio has a market cap or net worth of $74.75 million as of January 15, 2026. Its market cap has decreased by -5.61% in one year.
Market Cap
74.75M
Enterprise Value
66.38M
1-Year Change
-5.61%
Ranking
Category
Stock Price
$1.63
Market Cap Chart
Since June 28, 2018, Entera Bio's market cap has increased from $71.77M to $74.75M, an increase of 4.15%. That is a compound annual growth rate of 0.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 14, 2026 | 74.75M | -15.98% |
| Dec 31, 2025 | 88.96M | 13.93% |
| Dec 31, 2024 | 78.08M | 351.66% |
| Dec 29, 2023 | 17.29M | -17.80% |
| Dec 30, 2022 | 21.03M | -74.04% |
| Dec 31, 2021 | 81.03M | 308.59% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jun 28, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 961.00B |
| Johnson & Johnson | 526.55B |
| AbbVie | 392.16B |
| UnitedHealth Group | 303.42B |
| AstraZeneca | 299.25B |
| Novartis AG | 278.73B |
| Merck & Co. | 275.53B |
| Novo Nordisk | 262.20B |